Internal Assessment for 2011 International Review - CIHR Institute of Circulatory and Respiratory Health - Long Descriptions
Figure 2: Percent of Total CIHR Expenditures Related to ICRH Mandate Areas Over Time
fiscal year |
2000-01 |
2001-02 |
2002-03 |
2003-04 |
2004-05 |
2005-06 |
2006-07 |
2007-08 |
2008-09 |
2009-10 |
grant $ open |
22.43% |
24.40% |
24.69% |
24.36% |
24.56% |
23.44% |
22.04% |
23.13% |
22.43% |
22.12% |
grant $ strategic |
11.99% |
9.99% |
13.06% |
13.29% |
13.12% |
12.52% |
14.57% |
13.99% |
14.08% |
14.09% |
salary $ open |
19.07% |
17.52% |
18.16% |
19.69% |
18.02% |
18.33% |
18.70% |
19.80% |
18.90% |
19.44% |
salary $ strategic |
24.98% |
26.58% |
28.23% |
28.35% |
24.03% |
21.44% |
22.34% |
16.57% |
12.45% |
14.12% |
training $ open |
19.06% |
18.05% |
18.13% |
19.61% |
20.51% |
17.99% |
17.34% |
17.45% |
17.68% |
16.77% |
training $ strategic |
27.12% |
23.64% |
18.42% |
12.92% |
13.94% |
16.76% |
17.99% |
15.69% |
11.78% |
10.01% |
« Back to figure 2
Figure 3: Relative change in numbers of cardiovascular clinical trials publications since 1997 on an annual basis, comparing top 10 countries
|
1997 |
1998 |
1999 |
2000 |
2001 |
2002 |
2003 |
2004 |
2005 |
2006 |
2007 |
2008 |
Canada |
1.00 |
1.13 |
1.31 |
1.54 |
1.57 |
1.55 |
1.96 |
1.88 |
1.78 |
1.88 |
2.10 |
2.41 |
United States |
1.00 |
0.98 |
1.18 |
1.37 |
1.19 |
1.37 |
1.47 |
1.49 |
1.53 |
1.43 |
1.51 |
1.55 |
Germany |
1.00 |
1.22 |
1.38 |
1.58 |
1.38 |
1.47 |
1.76 |
1.65 |
2.01 |
1.60 |
1.71 |
1.65 |
United Kingdom |
1.00 |
1.20 |
1.34 |
1.39 |
1.44 |
1.41 |
1.42 |
1.46 |
1.69 |
1.27 |
1.68 |
1.57 |
Italy |
1.00 |
1.12 |
1.29 |
1.30 |
1.34 |
1.54 |
1.67 |
1.71 |
1.97 |
1.75 |
2.09 |
2.08 |
Netherlands |
1.00 |
1.04 |
1.31 |
1.60 |
1.57 |
1.49 |
1.82 |
1.89 |
1.90 |
1.81 |
2.03 |
1.99 |
France |
1.00 |
1.05 |
1.22 |
1.33 |
0.99 |
1.09 |
1.08 |
1.05 |
1.26 |
1.25 |
1.15 |
1.41 |
Japan |
1.00 |
0.92 |
1.15 |
1.17 |
1.23 |
1.39 |
1.37 |
1.40 |
1.52 |
1.39 |
1.52 |
1.50 |
Sweden |
1.00 |
1.13 |
1.45 |
1.42 |
1.39 |
1.56 |
1.39 |
1.58 |
1.78 |
1.27 |
1.56 |
1.72 |
Spain |
1.00 |
1.15 |
1.56 |
1.74 |
1.44 |
1.64 |
2.05 |
2.21 |
2.54 |
2.51 |
2.56 |
2.23 |
World |
1.00 |
1.03 |
1.24 |
1.30 |
1.20 |
1.31 |
1.42 |
1.40 |
1.52 |
1.44 |
1.52 |
1.54 |
« Back to figure 3
Figure 4: Specialization Index and Average of Relative Citations for Top 10 Countries Publishing Cardiovascular Clinical Trials (2000-2008)
Years |
Country |
Research Area |
Papers |
ARIF |
ARC |
SI |
2000 to 2008 |
World |
CIHR_Circulatory |
20978 |
1 |
1 |
1 |
2000 to 2008 |
United States |
CIHR_Circulatory |
6932 |
1.18659 |
1.311255 |
1.037343 |
2000 to 2008 |
Germany |
CIHR_Circulatory |
2533 |
1.10549 |
1.287025 |
1.490055 |
2000 to 2008 |
Italy |
CIHR_Circulatory |
2242 |
1.056571 |
1.161341 |
2.485877 |
2000 to 2008 |
United Kingdom |
CIHR_Circulatory |
2187 |
1.13174 |
1.27332 |
1.228169 |
2000 to 2008 |
Japan |
CIHR_Circulatory |
1885 |
0.818571 |
0.699259 |
1.08353 |
2000 to 2008 |
Netherlands |
CIHR_Circulatory |
1449 |
1.197752 |
1.39647 |
2.78031 |
2000 to 2008 |
Canada |
CIHR_Circulatory |
1384 |
1.228909 |
1.350718 |
1.46328 |
2000 to 2008 |
France |
CIHR_Circulatory |
1305 |
1.113362 |
1.415695 |
1.06545 |
2000 to 2008 |
Sweden |
CIHR_Circulatory |
875 |
1.075612 |
1.200108 |
2.285308 |
2000 to 2008 |
Spain |
CIHR_Circulatory |
738 |
0.982627 |
1.070166 |
1.077506 |
« Back to figure 4
- Date modified:
-